Clinical Trial Update: IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating accelerated radiotherapy with or without nimorazole for head and neck squamous cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Nimorazole (nimorazole)

Snippet

Sponsor: Danish Head and Neck Cancer Group | Conditions: Head and Neck Carcinoma | Phase 3 | Status: TERMINATED